RESEARCH FIELDBiological sciencesChemistryPharmacological sciences
RESEARCHER PROFILERecognised Researcher (R2)
APPLICATION DEADLINE23/08/2022 23:59 - Europe/Brussels
LOCATIONFrance › GIF SUR YVETTE
TYPE OF CONTRACTTemporary
HOURS PER WEEK35
OFFER STARTING DATE01/01/2023
The successful candidate will be in charge of the synthesis and characterization of:
- compounds sensitive to ionizing rays (NMR/LC-MS characterizations)
- multi-anchoring peptide ligands prepared on solid supports (SPPS) (LC-MS/Maldi characterizations)
- final multimodal macromolecules (LC-MS/Maldi characterizations)
After preparation/characterization and optimization of the final compounds, the candidate will evaluate them on tumor cell lines (toxicity (MTT assays), internalization/localization in tumor cells vs. healthy cells (ICP-MS and optical imaging)). The radio-amplifying effect and the synergistic effect (radio-amplification and action of the pro-drug) will be evaluated by quantification of clonogenic survival and compared with those obtained with conventional treatments combined or not. The diffusion of macromolecules within tumors and the synergistic effect of combined treatment will also be studied (3D cell models).
She/he will be responsible for writing laboratory notebooks/reports/publications.
The candidate will need solid experience in organic chemistry but will also have to adapt to the project's multidisciplinary nature.
As part of a Labex NanoSaclay/Charm3at project (SmartTher: Radio-activatable anti-cancer therapy), a 12-month postdoctoral research position in organic chemistry is available. This project, which ranges from the chemical synthesis of compounds to preliminary in vitro evaluations, focuses on designing anti-cancer drugs that can be activated by ionizing radiation and that target tumors for applications in radiotherapy/chemotherapy.
The candidate will integrate, at the ICSN, a group from the Department of Chemobiology composed of 3 permanent researchers. The effectiveness of these molecules in medical physics will be evaluated by a team from ISMO that studies anti-cancer compounds in cellulo under irradiation.
Context of the research project:
One out of two cancer patients is treated with radiotherapy. This treatment is, unfortunately, the cause of side effects on the surrounding healthy tissues and is not very effective on radioresistant cancers. Recent developments bring new avenues for greater efficiency, such as combining ionizing radiation with nano-objects based on heavy atoms (Z>50), amplifying the effects of ionizing radiation, or using pro-drugs of radiation-activatable cytotoxic agents.
We propose, in this project, to combine these last two strategies hoping to have a synergistic effect but also to improve the targeting of chemo and radiotoxic impact on the tumor. In this perspective, we propose to develop and test multimodal, radio-amplifying macromolecules capable of targeting tumors and releasing anti-cancer agents at these tumors' levels under ionizing irradiation. These radio and chemotherapeutic compounds will make it possible to amplify the damage caused to cancerous cells while limiting the side effects to other surrounding healthy cells. Breaking with conventional protocols, they should provide a breakthrough in treating cancers that are difficult to cure, such as cancers surrounded by susceptible healthy tissue or cancers resistant to traditional treatments.
At the interface of Chemistry, Physics, and Medicine, this project is interdisciplinary and requires varied expertise to carry out the synthesis/characterization of chemical compounds, the study of their toxicity, and their biological evaluation to study the synergistic effect associating pro-drug and radio-amplifiers.
The Institute of Chemistry of Natural Substances (ICSN) is a CNRS Research Unit whose research axes are chemistry and biology. It is part of the University of Paris-Saclay which, since 2015, has brought together research and education establishments in southern Paris. The ICSN is located on the Gif-sur-Yvette campus and has approximately 125 agents, including 76 permanent staff, spread over three buildings. Within the Department of Chemobiology (http://www.icsn.cnrs-gif.fr/spip.php?article1280), the recruited agent will join a group of 3 researchers and three doctoral students. He/she will be placed under the hierarchical authority of the team leader. The institute benefits from a privileged working environment for activities at the chemistry/biology interface with numerous platforms and equipment (https://icsn.cnrs.fr/plateformes).
ISMO (http://www.ismo.universite-paris-saclay.fr/spip.php?rubrique1) is a joint research unit of the CNRS and the University of Paris-Saclay, bringing together 159 people, 82 of whom are permanent. The institute is a center of excellence in three major scientific fields: molecular physics and its applications, nanosciences, and physics for biology. The Nanomedicine and Biophotonics team involved in this project carries out a cutting-edge interdisciplinary activity at the chemistry-physics-biology interface. It benefits from a large fleet of equipment (lasers, spectrometers, particle beams, super-resolution microscopes, beamline in partnership with SOLEIL, etc.) and collaborations for access to different types of radiation (proton, carbon …).
The candidate will have a Ph.D. in organic chemistry and research skills resulting in at least one publication as first/second author.
We are looking for a candidate with solid knowledge of organic synthesis, a good understanding of peptide synthesis, and willing to work at the chemistry/biology/medicine interface for biomedical applications.
An interdisciplinary chemistry/biology profile, particularly with peptide/pro-drug chemistry skills, will be appreciated.
The candidate must have organizational skills and a positive attitude to work in a team on multidisciplinary projects while respecting rules and procedures.
She/he should be fluent in French and English.
Two reference letters and contact details should be provided. The start date is ideally early January 2023.
Web site for additional job details
Required Research Experiences
YEARS OF RESEARCH EXPERIENCE1 - 4
RESEARCH FIELDBiological sciences
YEARS OF RESEARCH EXPERIENCE1 - 4
RESEARCH FIELDPharmacological sciences
YEARS OF RESEARCH EXPERIENCE1 - 4
REQUIRED EDUCATION LEVELChemistry: PhD or equivalentBiological sciences: PhD or equivalentPharmacological sciences: PhD or equivalent
REQUIRED LANGUAGESFRENCH: Basic
EURAXESS offer ID: 822001
Posting organisation offer ID: 31073
The responsibility for the jobs published on this website, including the job description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.
Please contact email@example.com if you wish to download all jobs in XML.